Search results

Blog

Drug Development Timelines: How Health Canada’s 30-Day Regulatory Review Process Could Provide an Advantage

May 3, 2023

The EMA recently updated their clinical trial application process. Discover how Health Canada's CTA process compares.
Scientific Publication

Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides

Apr 27, 2023
- Bioanalysis
Get the Facts: NDA-Enabling Studies

Apr 27, 2023
- Clinical Trials
Press Release

Altasciences Completes Clinical Portion of Alzamend Neuro's Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer's

Apr 18, 2023
Your Expert Guide to Developing Psychoactive Substances

Apr 13, 2023
- Clinical Trials
Blog

Four Key Steps to Optimizing a Large Molecule Bioanalytical Program

Apr 12, 2023

Learn how Altasciences advances your biologic drug development with robust bioanalytical support. Expertise in large molecule bioanalysis fosters program success.
- Bioanalysis
Get to Know the People and the Unique Approach That Make Altasciences a Different Kind of CRO/CDMO

Apr 10, 2023